[16] Stupp, R., Taillibert, S., Kanner, A.,et al. Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma. JAMA.2017.318(23).2306–2316. doi:10.1001/jama.2017.18718
[17] Denise Fabian, Maria del Pilar Guillermo Prieto Eibl, Iyad Alnahhas, et al.Treatment of Glioblastoma (GBM) with the Addition of Tumor-Treating Fields (TTF): A Review.Cancers.2019, 11(2), 174. doi: 10.3390/cancers11020174.
[18] Gregory F. Guzauskas, Erqi L. Pollom, Volker W. Stieber, Bruce C. Wang, Lou Garrison. Tumor treating fields treatment for patients with newly diagnosed glioblastoma: A cost-effectiveness analysis [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14–18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr LB-257.doi: 10.1158/1538-7445.AM2018-LB-257
- 有癌症，易房颤！韩国82万例患者研究
- 心衰治疗里程碑突破！首个miRNA药物证明安全有效！
- 深圳科学家提出肿瘤精准治疗新思路
- 淋巴瘤患者的福音！苏州大学探寻新的治疗靶点
- 晚期癌症只能活活痛死？癌症根本不用治？肿瘤科医生讲了四个真相
- 【医伴旅】200mg剂量的非戈替尼治疗中重度溃疡性结肠炎安全有效
- 癌症会一代传一代？父母若得了5种癌，子女可能会“继承”
- 医万个为什么 | 康焱：关节严重变形，为什么手术是唯一治疗方法？
- EULAR重磅更新：GRAPPA发布PsA治疗最新建议！IL-17抑制剂获一线推荐！
- 医疗|长期染发会致癌吗？提醒：一种染发剂与癌症相关，学会4个技巧